Thanks for the post stockdoc (look forward to synonymous' post as well).. like I said Ken took away the "ammunition" (folks can't seriously spread false info about zero revenue and no cash any longer.. and if false info is spread out there:).. longs can feel good about their investment based on facts:) I personally believe the endgame is a sale of the company but at much higher prices. My guess is that it would exceed the current internal valuation and would also include some kind of value placed on all of the companies coming into the program in 2023. By that time I estimate we will have uplisted and many of the current shareholders might already be gone because of nice gains. Imo very exciting times. No dilution and a business model that is being proven to the market in front of our eyes. Just imagine the opportunity for revenue growth going forward:). I LOVE the communication by Ken and company.. in my experience in the OTC very rare indeed.. Ken is clearly laying out the plan for those willing to listen:) Makes it much easier to filter out the noise:)
Hey 'stockdoc2' - Thanks for sharing your Bullet Points on Fridays Podcast.
NOTE: Ken said; "We are working feverishly to get the 3rd Qtr Report out before the 3rd or 4th week of October." I think there is a good reason for getting it out early so . . . I'm betting they will get it done!
News 
Market Data 
Discover 
AI
